https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-medline-removes-or-corrects-all-medline-brand-beds-and-accessories
Why MDLN Stock slipped -1.14% Today — RQD Quant Desk Flash
Medline Inc. (MDLN) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh money.
Why MDLN Stock slipped -1.14% Today — RQD Quant Desk Flash
Medline Inc. (MDLN) slipped -1.14% to $32.00 as options desks priced 55% call premium vs. 45% put protection around the $31 max-pain magnet. Stretched risk/reward at 5x P/E (8% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 3% of its 52-week range ($31.37 – $50.88) with RSI-14 at 31.6 (OVERSOLD (<32)).
- ▸Whale Options Positioning: $4.2M in bullish call flow vs. $3.4M in put flow (Put/Call 0.81x, implied earnings swing ±7.3%).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 26.4% gross margin and $1.3B annual free cash flow.
Medline's private fleet of truck drivers, MedTrans, recently completed its fourth annual National Truck Rodeo, which celebrates the drivers' commitment to safety and technical abilities. The company's fleet of more than
Mizuho analyst Steven Valiquette maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the price target from $48 to $45.
https://www.sec.gov/ix?doc=/Archives/edgar/data/0002046386/000110465926117844/tm2627900d1_8k.htm
The fund bought $28.2 million of Medline and $24.3 million of Amphenol while selling $35.8 million of Apollo and $33.4 million of CVS.
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring MDLN)
- ✓Live walkthrough of MDLN's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
MDLN Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +11.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MDLN today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MDLN. Explore sector supply chains on /butterfly.
MDLN Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is MDLN stock moving today?
Why MDLN Stock slipped -1.14% Today — RQD Quant Desk Flash. Stretched risk/reward at 5x P/E (8% return on capital) under elevated 10-year interest-rate pressure.